Article

Isomeric acetoxy analogues of rofecoxib: A novel class of highly potent and selective cyclooxygenase-2 inhibitors

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Bioorganic & Medicinal Chemistry Letters (Impact Factor: 2.33). 11/2002; 12(19):2753-6. DOI: 10.1016/S0960-894X(02)00537-1
Source: PubMed

ABSTRACT A group of isomers possessing a 2-, 3-, or 4-acetoxy moiety on the 3-phenyl substituent of rofecoxib were synthesized that exhibit highly potent, and selective, COX-2 inhibitory activity that have the potential to acetylate the COX-2 isozyme.

Full-text

Available from: Edward E Knaus, Jan 20, 2014
0 Followers
 · 
49 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: A group of rofecoxib analogs, having a sulfonylazide (SO2N3) substituent in place of the methanesulfonyl (SO2CH3) pharmacophore at the meta-position viz 3-(4-methyl, 4-methoxy, or 4-ethoxyphenyl)-4-(3-sulfonylazidophenyl)-2(5H)furanone (7a-c) and para-position viz 3-phenyl-4-(4-sulfonylazidophenyl)-2(5H)furanone (7d), 3-(4-fluoro, or 4-chlorophenyl)-4-(4-sulfonylazidophenyl)-2(5H)furanone (7e-f) of the C–4 phenyl ring, and 4-(1-oxido-4-pyridyl)-3-phenyl-2(5H)furanone (12) were designed and synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. In vitro COX-1/COX-2 enzyme inhibition studies showed that 3-phenyl-4-(4-sulfonylazidophenyl)-2(5H)furanone (7d) inhibited COX-1 selectively (COX-1 IC50 = 0.6659 μM; COX-2 IC50 > 100 μM) and 3-(4-fluorophenyl)-4-(4-sulfonylazidophenyl)-2(5H)furanone (7e) inhibited both enzymes (COX-1 IC50 = 0.8494 μM; COX-2 IC50 = 1.7661 μM). A molecular modeling study was performed where 3-(4-fluorophenyl)-4-(4-sulfonylazidophenyl)-2(5H)furanone (7e) was docked in the active site of murine COX-2 isozyme, which showed that the sulfonylazido group inserts deep into the 2°-pocket of COX-2 where it undergoes both H-bonding (Gln192, Phe518) and weak electrostatic (Arg513) interactions.
    Journal of Heterocyclic Chemistry 03/2004; 40(5):861 - 868. DOI:10.1002/jhet.5570400518 · 0.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aromatic substituents migrate in a novel oxidative cyclization mediated by iodine(III) reagents. 4-Arylbut-3-enoic acids are cyclized and rearranged to 4-arylfuran-2(5H)-ones by hypervalent iodine compounds in good to excellent yields under mild reaction conditions. Other ring sizes are also accessible. The mechanism of the reaction is described in detail, and calculations highlight the cationic nature of the intermediates in the rearrangement. The fast access to heavily substituted furanones is used for the synthesis of biologically active derivatives.
    ChemistryOpen 12/2012; 1(6):245-50. DOI:10.1002/open.201200037 · 2.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Using KF as base and THF as solvent, 5-alkoxy-3,4-dihalo-2(5H)-furanones were reacted with secondary amines. The normal products, β-amino-2(5H)-furanones, were obtained via the tandem Michael addition-elimination reaction as expected in most cases. However, the reaction between diisopropylamine and 3,4-dihalo-5-methoxy-2(5H)-furanones yielded unanticipated products, methyl (E)-2-halo-4-(diisopropylamino)-4-oxobut-2-enoates. The possible synthetic mechanism involving a rearrangement reaction was proposed. The biological activity assay of products derived from the reactions of 5-alkoxy-3,4-dihalo-2(5H)-furanones with different amino compounds was preliminarily investigated by the MTT method on A549 cells in vitro, which revealed that some derivatives of amino acid esters with a benzene ring exhibited the best anticancer bioactivity. Graphical Abstract
    Monatshefte fuer Chemie/Chemical Monthly 06/2012; 143(3). DOI:10.1007/s00706-011-0594-3 · 1.35 Impact Factor